Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Psychotic Disorders
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The present study aims to investigate whether transcranial direct current stimulation (tDCS) reduces auditory hallucinations in patients with psychosis. In addition, the neuronal changes of tDCS will be examined.

Provided treatments

  • Device: DC Stimulator PLUS (NeuroConn)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02769507. The sponsor of the trial is University of Bergen and it is looking for 60 volunteers for the current phase.
Official trial title:
Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations